Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of vonoprazan 20 mg film-coated tablet vs VOCINTI 20 mg in healthy Thai volunteers under fasting conditions
TCTR20250606002Phase 1Not yet recruiting
- Sponsor
- Bio-innova
- Start
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of vonoprazan (2 arms), sponsored by Bio-innova. Planned start Sep 2025; status: not yet recruiting.
02
Drugs
vonoprazan
Beyond the preview
Go deeper on TCTR20250606002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20250606002.